Influenza: incidence, symptoms and treatment
- PMID: 16509437
- DOI: 10.12968/bjon.2005.14.22.20172
Influenza: incidence, symptoms and treatment
Abstract
Influenza is a common respiratory condition that has a history of developing into epidemics and pandemics. Individuals at risk of influenza and related complications include older people, young children and individuals with chronic renal, cardiac and respiratory diseases. Influenza can begin suddenly and is accompanied by fever, chills, aches, pains, headaches, fatigue, cough and generalized weakness that can last up to 14 days. Complications of influenza include secondary bacterial pneumonia, post-influenza encephalitis, changes in cardiac electrocardiogram and secondary bacterial infections, such as Staphylococcus aureus-induced myositis. The influenza vaccine is the main form of treatment. Suitably qualified nurse prescribers and nurses who supply and administer the vaccine under patient group directions should be sufficiently knowledgeable about the virus and how its transmission can be prevented in order to educate patients at risk of developing influenza about the role of the vaccine in the prevention of the disease.
Similar articles
-
Antiviral drugs in influenza: an adjunct to vaccination in some situations.Prescrire Int. 2006 Feb;15(81):21-30. Prescrire Int. 2006. PMID: 16548114
-
Novel influenza A (H1N1): what nurses need to know.Medsurg Nurs. 2009 Sep-Oct;18(5):302-4. Medsurg Nurs. 2009. PMID: 19927968 No abstract available.
-
'Tis the season for influenza.Nurse Pract. 2006 Dec;31(12):24-33; quiz 34-5. doi: 10.1097/00006205-200612000-00006. Nurse Pract. 2006. PMID: 17149132 Review. No abstract available.
-
Complications of seasonal and pandemic influenza.Crit Care Med. 2010 Apr;38(4 Suppl):e91-7. doi: 10.1097/CCM.0b013e3181c92eeb. Crit Care Med. 2010. PMID: 19935413 Review.
-
Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.Vaccine. 2011 Jun 20;29(28):4632-7. doi: 10.1016/j.vaccine.2011.04.064. Epub 2011 May 6. Vaccine. 2011. PMID: 21550376
Cited by
-
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens.Viruses. 2025 Feb 12;17(2):252. doi: 10.3390/v17020252. Viruses. 2025. PMID: 40007007 Free PMC article. Review.
-
Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):512. doi: 10.1186/s12859-016-1374-1. BMC Bioinformatics. 2016. PMID: 28155702 Free PMC article.
-
Acute Influenza B Infection Presenting as Cardiac Tamponade: A Case Report.Cureus. 2020 Nov 30;12(11):e11799. doi: 10.7759/cureus.11799. Cureus. 2020. PMID: 33409044 Free PMC article.
-
A comprehensive review of influenza B virus, its biological and clinical aspects.Front Microbiol. 2024 Sep 4;15:1467029. doi: 10.3389/fmicb.2024.1467029. eCollection 2024. Front Microbiol. 2024. PMID: 39296301 Free PMC article. Review.
-
Forecasting influenza hemagglutinin mutations through the lens of anomaly detection.Sci Rep. 2023 Sep 11;13(1):14944. doi: 10.1038/s41598-023-42089-y. Sci Rep. 2023. PMID: 37696867 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical